Argitalpenak (146) MIGUEL FERNÁNDEZ ARQUERO argitalpenak

2024

  1. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression

    Journal of Clinical Immunology, Vol. 44, Núm. 6

  2. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure

    Scientific Reports, Vol. 14, Núm. 1

  3. Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study

    Frontiers in Immunology, Vol. 15

  4. Exploring gastric cancer genetics: A turning point in common variable immunodeficiency

    Journal of Allergy and Clinical Immunology: Global, Vol. 3, Núm. 2

  5. Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study

    Experimental Dermatology, Vol. 33, Núm. 8

2023

  1. A unique association? A narcolepsy type 1 case comorbid with Primary Biliary Cholangitis

    Sleep Medicine, Vol. 110, pp. 180-182

  2. Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa

    British Journal of Dermatology, Vol. 189, Núm. 6, pp. 774-776

  3. Inherited human ezrin deficiency impairs adaptive immunity

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 4, pp. 997-1009.e11

  4. Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression

    Biomedicines, Vol. 11, Núm. 4

  5. Myeloid-derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure: Increased levels of MDSCs in recurrent reproductive failure

    American Journal of Reproductive Immunology, Vol. 90, Núm. 5

  6. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

2022

  1. Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

    Journal of Translational Autoimmunity, Vol. 5

  2. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement

    Frontiers in Immunology, Vol. 13

  3. Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression

    Biomedicines, Vol. 10, Núm. 8

  4. Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

    Frontiers in Oncology, Vol. 12

  5. Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency

    Frontiers in Immunology, Vol. 13

  6. Immunophenotyping of peripheral blood monocytes could help identify a baseline pro-inflammatory profile in women with recurrent reproductive failure

    Journal of Reproductive Immunology, Vol. 154

  7. Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases

    Journal of Clinical Medicine Research, Vol. 14, Núm. 8, pp. 309-314

2021

  1. Antígeno leucocitario humano C y receptores tipo inmunoglobulina en medicina reproductiva

    Medwave, Vol. 21, Núm. 10, pp. e8484

  2. Clinical and Immunological Features of Human BCL10 Deficiency

    Frontiers in Immunology, Vol. 12